IMPROVE OUTCOMES | REDUCE RISK

Device-Events-638x150

IMPROVE OUTCOMES | REDUCE RISK

IMPROVE OUTCOMES | REDUCE RISK

FDA says Philips knew about toxic foam for years before massive recall

Date

Medical Design & Outsourcing – November 16, 2021 – By Jim Hammerand 

The FDA said it observed potential violations of federal medical device safety rules when inspecting a Philips Respironics manufacturing facility connected to the Class I recall of more than 15 million respiratory devices.

The FDA recently requested additional safety testing on replacement materials and issued a Form 483. The form details how Philips and its foam supplier were aware for years that polyester-based polyurethane (PE-PUR) sound abatement foam could break down and potentially enter a device’s air pathway, causing health problems for users.

In the Form 483, FDA alerted management at the Royal Philips (NYSE:PHG) subsidiary of conditions that the inspector considered possible violations of the U.S. Food, Drug and Cosmetic Act or related regulations. The post-inspection report is not a determination of wrongdoing and will be considered by the FDA along with any evidence or documents collected from the facility and responses offered by Philips.

Read Full Article…

More
articles

Drag